Recent Advances in Human Fungal Diseases

Dr. Saif Hameed is currently an associate professor at Amity Institute of Biotechnology, Amity University Haryana (AUH), India. Dr. Hameed did his Bachelors’s from University of Delhi and Masters’s from Jamia Hamdard in 2003 and 2005 respectively. He did his doctoral studies in Life Sciences at Jawaharlal Nehru University in 2010 where he also received CSIR research associateship for the one-year postdoctoral work. He worked as visiting scholar at Institut für Mikrobiologie, Heinrich-Heine-Universität, Düsseldorf, Germany in 2008. He received the Young Scientist award under the fast-track Scheme from the science and engineering research board, Department of Science and Technology, New Delhi in the year 2012. He is a life member of the International Society of Infectious Diseases (ISID), Association for Microbiologists (AMI), India and Society of Biological Chemists (SBC), India. Dr. Hameed is actively engaged in research in the field of medical microbiology particularly antibiotic resistance in pathogenic fungi. He has 70 peer-reviewed papers to his credit in international journals of repute along with 6 books. He has supervised 6 PhD students and guided 25 UG and PG level students for their research projects.Dr. Pooja Vijayaraghavan is a as professor at Amity University Uttar Pradesh, Noida, India. She is a prominent scientist in the field of antifungal research. Her major focus area is to evaluate the biological efficacy of naturally occurring small molecules and synthetically designed analogues against pathogenic fungal species, with a particular emphasis on human pathogens such as Aspergillus fumigatus and Rhizopus oryzae, along with plant pathogenic fungi like Magnaporthe oryzae and Curvularia lunata. She has published many peer-reviewed articles which have provided invaluable global perspectives and insights. Dr. Vijayaraghavan has obtained 17+ patents, with four patents already granted and others currently undergoing scrutiny. Her research has successfully transformed three patented innovations into practical products in collaboration with various industries. These include a herbal hand sanitizer, a biopolymer-based film for enhancing the shelf life of perishable fruits and vegetables, and a biopesticide to combat rice blast disease.

• Part I. Candida and candidiasis.- Chapter 1. Diagnosis of candida and candidiasis: current methods and future challenges.- Chapter 2. Fungal fighters: a comprehensive guide to antifungal therapies of the past, present and future.- Chapter 3. Candidiasis treatment: an evolutionary journey from past to present and a glimse into the future.- Chapter 4. MDR in candida: the real storm.- Chapter 5. Surviving the storm: how candida species master adaptation for pathogenesis.- Chapter 6. Molecular cues and mechanisms of pathogenesis in candida.- Chapter 7. Factors affecting drug resistance and virulence in fungal pathogen.- Chapter 8. Unravelling drug resistance in candida species: genetic, biofilm, transcriptional and epigenetic perspectives.- Chapter 9. Biofilm formation in candida species.- Chapter 10. Candida auris biofilm: a medical ambrosia.- Chapter 11. Candida albicans mixed species biofilms and associated antimicrobial resistance.- Chapter 12. Decoding the complex terrain of candida tropicalis induced candidiasis: insights into epidemology, infection mechanisms, theraputics and drug resistance.- Chapter 13. Candiasis drug resistance and translational research.- Part II. Aspergillus and aspergillosis.- Chapter 14. Therapeutic strategies and challenges in the management of aspergillus infections.- Chapter 15. Aspergillus therapeutics: future agents.- Chapter 16. Recent advances in the management of aspergillosis.- Chapter 17. Drug resistance patterns in opportunistic aspergilli: a molecular perspective.- Chapter 18. A comprehensive and intricate dynamics of aspergillus: implications, therapeutic challenges, and drug resistance.- Chapter 19. Understanding molecular pathogenesis of aspergillus fumigatus.